VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,471,977 | -10.6% | 54,700 | 0.0% | 0.62% | -13.8% |
| Q2 2023 | $1,647,017 | -6.9% | 54,700 | 0.0% | 0.72% | -22.5% |
| Q1 2023 | $1,769,545 | +77.9% | 54,700 | +57.6% | 0.93% | +94.4% |
| Q4 2022 | $994,502 | +18.8% | 34,700 | 0.0% | 0.48% | +1.3% |
| Q3 2022 | $837,000 | -11.9% | 34,700 | 0.0% | 0.47% | -5.2% |
| Q2 2022 | $950,000 | -28.6% | 34,700 | 0.0% | 0.50% | -22.1% |
| Q1 2022 | $1,331,000 | +2.1% | 34,700 | -14.7% | 0.64% | +20.1% |
| Q4 2021 | $1,304,000 | -58.1% | 40,700 | -61.5% | 0.53% | -54.1% |
| Q3 2021 | $3,115,000 | -13.3% | 105,700 | 0.0% | 1.16% | +27.3% |
| Q2 2021 | $3,592,000 | +4.6% | 105,700 | 0.0% | 0.91% | -1.3% |
| Q1 2021 | $3,435,000 | +5.1% | 105,700 | +16.5% | 0.92% | +4.8% |
| Q4 2020 | $3,267,000 | -8.0% | 90,700 | 0.0% | 0.88% | +47.4% |
| Q3 2020 | $3,552,000 | +6.8% | 90,700 | 0.0% | 0.60% | +50.0% |
| Q2 2020 | $3,327,000 | +59.2% | 90,700 | 0.0% | 0.40% | +73.8% |
| Q1 2020 | $2,090,000 | -21.3% | 90,700 | 0.0% | 0.23% | +40.5% |
| Q4 2019 | $2,656,000 | +9.6% | 90,700 | 0.0% | 0.16% | -15.1% |
| Q3 2019 | $2,423,000 | +56.2% | 90,700 | +49.4% | 0.19% | +50.0% |
| Q2 2019 | $1,551,000 | +14.0% | 60,700 | 0.0% | 0.13% | +21.9% |
| Q1 2019 | $1,361,000 | +32.5% | 60,700 | +24.6% | 0.10% | +23.5% |
| Q4 2018 | $1,027,000 | +34.6% | 48,700 | +18.2% | 0.08% | +51.8% |
| Q3 2018 | $763,000 | -17.0% | 41,200 | 0.0% | 0.06% | -9.7% |
| Q2 2018 | $919,000 | +1.4% | 41,200 | 0.0% | 0.06% | 0.0% |
| Q1 2018 | $906,000 | -5.3% | 41,200 | 0.0% | 0.06% | +3.3% |
| Q4 2017 | $957,000 | +1.2% | 41,200 | 0.0% | 0.06% | -20.0% |
| Q3 2017 | $946,000 | +21.8% | 41,200 | +17.0% | 0.08% | +44.2% |
| Q2 2017 | $777,000 | -3.2% | 35,200 | 0.0% | 0.05% | +8.3% |
| Q1 2017 | $803,000 | +9.1% | 35,200 | 0.0% | 0.05% | -5.9% |
| Q4 2016 | $736,000 | -20.9% | 35,200 | 0.0% | 0.05% | -38.6% |
| Q3 2016 | $930,000 | +40.5% | 35,200 | +47.3% | 0.08% | +48.2% |
| Q2 2016 | $662,000 | – | 23,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |